Memantina Lanoratorio Stada, S.L. (Memantine)

Memantine works as a non‑competitive antagonist of the NMDA receptor. By blocking excessive calcium influx through the receptor’s ion channel, it limits glutamate‑induced excitotoxicity while allowing normal synaptic transmission, thereby protecting neurons in Alzheimer’s disease.

The appropriate dose of memantine is determined by the prescribing clinician based on the patient’s condition, age, renal function, and other factors. Dosage adjustments are individualized and should follow the prescriber’s instructions.

The safety of memantine in pregnancy and lactation has not been established. It is classified as pregnancy category unknown, and clinicians usually weigh potential benefits against risks before prescribing to pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Memantine belongs to the NMDA receptor antagonist class, whereas cholinesterase inhibitors such as donepezil act on acetylcholine metabolism. Memantine is typically used for moderate to severe stages, often in combination with a cholinesterase inhibitor, offering a complementary mechanism of neuroprotection.

Store the product below 25 °C in its original packaging, protecting it from moisture and direct sunlight. Ensure the container is tightly closed and keep it out of reach of children.

Memantina Lanoratorio is administered orally, usually as a tablet taken with or without food. The exact administration schedule should follow the prescriber’s directions.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, seizures, cardiac arrhythmias, hepatic injury, and suicidal thoughts. Patients should seek immediate medical attention if they experience any of these symptoms.

Memantine is contraindicated in patients with known hypersensitivity to the drug or any of its excipients. Caution is advised for individuals with severe renal impairment, uncontrolled hypertension, or a history of seizures.